vs
Side-by-side financial comparison of Postal Realty Trust, Inc. (PSTL) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.
Postal Realty Trust, Inc. is the larger business by last-quarter revenue ($26.0M vs $20.4M, roughly 1.3× Sight Sciences, Inc.). Postal Realty Trust, Inc. runs the higher net margin — 17.9% vs -20.4%, a 38.3% gap on every dollar of revenue. On growth, Postal Realty Trust, Inc. posted the faster year-over-year revenue change (21.7% vs 6.9%). Postal Realty Trust, Inc. produced more free cash flow last quarter ($37.6M vs $-2.0M). Over the past eight quarters, Postal Realty Trust, Inc.'s revenue compounded faster (22.6% CAGR vs 2.9%).
Postal Realty Trust, Inc. is a specialized real estate investment trust that acquires, owns, and manages properties primarily leased to the United States Postal Service. Its portfolio includes last-mile postal facilities, sorting centers, and retail post office locations across the U.S., supporting critical mail and package delivery infrastructure.
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
PSTL vs SGHT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.0M | $20.4M |
| Net Profit | $4.6M | $-4.2M |
| Gross Margin | — | 87.3% |
| Operating Margin | 39.2% | -18.0% |
| Net Margin | 17.9% | -20.4% |
| Revenue YoY | 21.7% | 6.9% |
| Net Profit YoY | 3.1% | 64.9% |
| EPS (diluted) | $0.16 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.0M | $20.4M | ||
| Q3 25 | $24.3M | $19.9M | ||
| Q2 25 | $23.4M | $19.6M | ||
| Q1 25 | $22.1M | $17.5M | ||
| Q4 24 | $21.4M | $19.1M | ||
| Q3 24 | $19.7M | $20.2M | ||
| Q2 24 | $18.1M | $21.4M | ||
| Q1 24 | $17.3M | $19.3M |
| Q4 25 | $4.6M | $-4.2M | ||
| Q3 25 | $3.8M | $-8.2M | ||
| Q2 25 | $3.6M | $-11.9M | ||
| Q1 25 | $2.1M | $-14.2M | ||
| Q4 24 | $4.5M | $-11.8M | ||
| Q3 24 | $1.1M | $-11.1M | ||
| Q2 24 | $817.0K | $-12.3M | ||
| Q1 24 | $206.0K | $-16.3M |
| Q4 25 | — | 87.3% | ||
| Q3 25 | — | 86.4% | ||
| Q2 25 | — | 84.8% | ||
| Q1 25 | — | 86.2% | ||
| Q4 24 | — | 86.8% | ||
| Q3 24 | — | 83.9% | ||
| Q2 24 | — | 85.8% | ||
| Q1 24 | — | 85.5% |
| Q4 25 | 39.2% | -18.0% | ||
| Q3 25 | 37.6% | -39.7% | ||
| Q2 25 | 37.3% | -59.6% | ||
| Q1 25 | 28.4% | -79.2% | ||
| Q4 24 | 43.2% | -62.5% | ||
| Q3 24 | 24.3% | -55.7% | ||
| Q2 24 | 22.8% | -59.2% | ||
| Q1 24 | 17.6% | -76.4% |
| Q4 25 | 17.9% | -20.4% | ||
| Q3 25 | 15.7% | -41.0% | ||
| Q2 25 | 15.5% | -61.0% | ||
| Q1 25 | 9.4% | -80.8% | ||
| Q4 24 | 21.1% | -62.1% | ||
| Q3 24 | 5.4% | -54.9% | ||
| Q2 24 | 4.5% | -57.7% | ||
| Q1 24 | 1.2% | -84.4% |
| Q4 25 | $0.16 | $-0.07 | ||
| Q3 25 | $0.13 | $-0.16 | ||
| Q2 25 | $0.12 | $-0.23 | ||
| Q1 25 | $0.06 | $-0.28 | ||
| Q4 24 | $0.17 | $-0.23 | ||
| Q3 24 | $0.03 | $-0.22 | ||
| Q2 24 | $0.02 | $-0.25 | ||
| Q1 24 | $-0.01 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.5M | $92.0M |
| Total DebtLower is stronger | $361.1M | $42.4M |
| Stockholders' EquityBook value | $285.2M | $63.9M |
| Total Assets | $759.1M | $115.3M |
| Debt / EquityLower = less leverage | 1.27× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5M | $92.0M | ||
| Q3 25 | $1.9M | $92.4M | ||
| Q2 25 | $1.1M | $101.5M | ||
| Q1 25 | $639.0K | $108.8M | ||
| Q4 24 | $1.8M | $120.4M | ||
| Q3 24 | $970.0K | $118.6M | ||
| Q2 24 | $1.7M | $118.2M | ||
| Q1 24 | $1.9M | $127.3M |
| Q4 25 | $361.1M | $42.4M | ||
| Q3 25 | $347.0M | $42.4M | ||
| Q2 25 | $328.8M | $42.4M | ||
| Q1 25 | $306.7M | $42.4M | ||
| Q4 24 | $296.7M | $40.0M | ||
| Q3 24 | $277.0M | $37.1M | ||
| Q2 24 | $273.7M | $35.0M | ||
| Q1 24 | $247.6M | $35.0M |
| Q4 25 | $285.2M | $63.9M | ||
| Q3 25 | $273.9M | $64.3M | ||
| Q2 25 | $250.8M | $70.0M | ||
| Q1 25 | $245.5M | $77.6M | ||
| Q4 24 | $251.3M | $87.5M | ||
| Q3 24 | $245.6M | $95.0M | ||
| Q2 24 | $245.5M | $101.6M | ||
| Q1 24 | $248.1M | $109.2M |
| Q4 25 | $759.1M | $115.3M | ||
| Q3 25 | $735.2M | $116.3M | ||
| Q2 25 | $689.8M | $122.0M | ||
| Q1 25 | $654.0M | $129.7M | ||
| Q4 24 | $646.8M | $142.8M | ||
| Q3 24 | $615.1M | $143.6M | ||
| Q2 24 | $608.2M | $149.7M | ||
| Q1 24 | $584.1M | $155.6M |
| Q4 25 | 1.27× | 0.66× | ||
| Q3 25 | 1.27× | 0.66× | ||
| Q2 25 | 1.31× | 0.61× | ||
| Q1 25 | 1.25× | 0.55× | ||
| Q4 24 | 1.18× | 0.46× | ||
| Q3 24 | 1.13× | 0.39× | ||
| Q2 24 | 1.11× | 0.34× | ||
| Q1 24 | 1.00× | 0.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $44.5M | $-1.8M |
| Free Cash FlowOCF − Capex | $37.6M | $-2.0M |
| FCF MarginFCF / Revenue | 144.5% | -9.7% |
| Capex IntensityCapex / Revenue | 26.7% | 0.8% |
| Cash ConversionOCF / Net Profit | 9.59× | — |
| TTM Free Cash FlowTrailing 4 quarters | $65.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $44.5M | $-1.8M | ||
| Q3 25 | $10.9M | $-8.7M | ||
| Q2 25 | $11.4M | $-7.5M | ||
| Q1 25 | $10.8M | $-11.6M | ||
| Q4 24 | $33.5M | $-3.5M | ||
| Q3 24 | $8.0M | $362.0K | ||
| Q2 24 | $9.9M | $-9.5M | ||
| Q1 24 | $6.4M | $-9.8M |
| Q4 25 | $37.6M | $-2.0M | ||
| Q3 25 | $8.8M | $-8.9M | ||
| Q2 25 | $9.1M | $-7.8M | ||
| Q1 25 | $10.2M | — | ||
| Q4 24 | $30.7M | $-3.6M | ||
| Q3 24 | $7.4M | $311.0K | ||
| Q2 24 | $8.9M | $-9.5M | ||
| Q1 24 | $5.8M | $-9.9M |
| Q4 25 | 144.5% | -9.7% | ||
| Q3 25 | 36.1% | -44.7% | ||
| Q2 25 | 38.8% | -39.6% | ||
| Q1 25 | 45.9% | — | ||
| Q4 24 | 143.8% | -18.9% | ||
| Q3 24 | 37.6% | 1.5% | ||
| Q2 24 | 49.4% | -44.7% | ||
| Q1 24 | 33.6% | -51.4% |
| Q4 25 | 26.7% | 0.8% | ||
| Q3 25 | 8.9% | 0.9% | ||
| Q2 25 | 10.1% | 1.1% | ||
| Q1 25 | 3.0% | 0.0% | ||
| Q4 24 | 13.0% | 0.7% | ||
| Q3 24 | 3.2% | 0.3% | ||
| Q2 24 | 5.4% | 0.4% | ||
| Q1 24 | 3.5% | 0.6% |
| Q4 25 | 9.59× | — | ||
| Q3 25 | 2.87× | — | ||
| Q2 25 | 3.16× | — | ||
| Q1 25 | 5.20× | — | ||
| Q4 24 | 7.44× | — | ||
| Q3 24 | 7.48× | — | ||
| Q2 24 | 12.10× | — | ||
| Q1 24 | 31.07× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PSTL
Segment breakdown not available.
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
